ICS line text

This website uses cookies to ensure you get the best experience on our website. Learn more


Recombinant AdenoAssociated Virus (rAAV): from molecular tools to gene therapy

Open in full size


Organisé(e) par Modèles murins pour les maladies humaines, Nicolas CHARLET BERGUERAND, Gérard GRADWOHL, Yann HERAULT, Philippe KASTNER, Daniel METZGER, Arnaud POTERSZMAN, Bernardo REINA SAN MARTIN


14h00 - 14h40: AUBOURG Patrick, "Towards tailored gene therapy for CNS diseases"

14h40 - 15h20 : ADJALI Oumeya, "AAV-mediated gene transfer to the skeletal muscle: immunity versus tolerance"

15h20 - 16h00: GARCIA Luis "Dystrophin rescue in animal model of Duchenne muscular dystrophy: AAV(U7) versus Antisense Oligonucleotide"

16h00 - 16h30: Coffee break

16h30 - 17h00: KOEBEL Pascale,"rAAV production at IGBMC by the BioMol & Virus core Service"

17h00 - 17h30: COWLING Belinda,"AAV use in mouse models of congenital myopathies"

17h30 - 18h00:BEILSCHMIDT Lena-Kristina, "In vivo AAV-based shRNA approach to study biogenesis of Fe-S proteins"


Illkirch, France

Associated document

search icon